These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 83413

  • 21. [General pharmacology of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic].
    Tone H, Kiyosaki T, Nishimori T, Kobayashi F, Nishimura K, Morino H, Tsuchiyama M.
    Jpn J Antibiot; 1986 Feb; 39(2):526-46. PubMed ID: 3712756
    [Abstract] [Full Text] [Related]

  • 22. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S.
    Arzneimittelforschung; 1985 Feb; 35(7A):1163-72. PubMed ID: 3000392
    [Abstract] [Full Text] [Related]

  • 23. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K, Fujita S, Umezato M, Hosoki E, Toba Y, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [Abstract] [Full Text] [Related]

  • 24. [General pharmacology of T-2588, a new oral cephem antibiotic].
    Hirai S, Kodama T, Hiraiwa T, Abe N, Arai H, Ono S, Omori M, Nakada Y, Hashiba K, Tanada K.
    Jpn J Antibiot; 1986 Apr; 39(4):958-78. PubMed ID: 3761550
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)].
    Ochiai T, Fukuchi I, Ego H, Yamamura M, Kudo Y, Ishida R.
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456
    [Abstract] [Full Text] [Related]

  • 31. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
    Shibata K, Mita I, Shinoda Y, Nakano U, Kinoshita H, Noguchi M, Uzawa T, Sohmiya Y, Takayanagi N.
    Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Toxicological studies on pepleomycin sulfate (NK 631). I. Acute toxicity of pepleomycin in mice, rats and dogs (author's transl)].
    Ito K, Irie Y, Miyamoto K, Yamashita T, Tsubosaki M, Matsuda A, Konoha N.
    Jpn J Antibiot; 1978 Dec; 31(12):719-37. PubMed ID: 83404
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.